These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29667728)

  • 41. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daylight photodynamic therapy in 25 patients with actinic keratosis and evaluation of efficacy by confocal microscopy.
    Sousa ACDS; Campos MAC; Baptista AM; Menezes NMBVN
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():414-416. PubMed ID: 30721758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MAL Daylight Photodynamic Therapy for Actinic Keratosis: Clinical and Imaging Evaluation by 3D Camera.
    Cantisani C; Paolino G; Pellacani G; Didona D; Scarno M; Faina V; Gobello T; Calvieri S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Split-face study comparing conventional MAL photodynamic therapy in multiple actinic keratosis with complete time vs. half-time red light LED conventional illumination.
    Fernández-Guarino M; Fonda Pascual P; Lizuain Gomez P; Harto Castaño A; Jaén Olasolo P
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1529-1534. PubMed ID: 30868672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.
    Piffaretti F; Zellweger M; Kasraee B; Barge J; Salomon D; van den Bergh H; Wagnières G
    Dermatology; 2013; 227(3):214-25. PubMed ID: 24135436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Actinic Keratosis with Photodynamic Therapy Using Red or Green Light: A Comparative Study.
    Osiecka BJ; Nockowski P; Szepietowski JC
    Acta Derm Venereol; 2018 Jul; 98(7):689-693. PubMed ID: 29963684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses.
    Neittaanmäki-Perttu N; Karppinen TT; Tani T; Snellman E; Grönroos M
    Acta Derm Venereol; 2017 Jan; 97(1):120-121. PubMed ID: 27304514
    [No Abstract]   [Full Text] [Related]  

  • 51. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility of daylight-mediated photodynamic therapy for actinic keratosis throughout the year in Central and South America: a meteorological study.
    Grinblat B; Galimberti G; Pantoja G; Sanclemente G; Lopez M; Alcala D; Torezan L; Kerob D; Pascual T; Chouela E
    Int J Dermatol; 2016 Sep; 55(9):e488-93. PubMed ID: 27061814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation.
    Kim HS; Yoo JY; Cho KH; Kwon OS; Moon SE
    Dermatol Surg; 2005 Jan; 31(1):33-6; discussion 36-7. PubMed ID: 15720093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.
    Bissonnette R; Bolduc C; Maari C; Nigen S
    J Am Acad Dermatol; 2012 Dec; 67(6):1386-7. PubMed ID: 23158619
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
    Togsverd-Bo K; Lei U; Erlendsson AM; Taudorf EH; Philipsen PA; Wulf HC; Skov L; Hædersdal M
    Br J Dermatol; 2015 Feb; 172(2):467-74. PubMed ID: 24975199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms.
    Fai D; Fai C; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2019 Oct; 154(5):603-605. PubMed ID: 29485253
    [No Abstract]   [Full Text] [Related]  

  • 60. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.